29 results
8-K
COCP
Cocrystal Pharma Inc
28 Oct 13
Termination of a Material Definitive Agreement
12:00am
”) related to a voluntary recall initiated by Matrixx on December 18, 2012 of one lot of Zicam® Extreme Congestion Relief nasal gel that BioZone Labs … manufactured on Matrixx’ behalf (the “Product Recall”).
In connection with the Product Recall, Matrixx sent BioZone Labs on January 3, 2013 a Notice
8-K
EX-2.1
COCP
Cocrystal Pharma Inc
8 Jan 14
Completion of Acquisition or Disposition of Assets
12:00am
or, to the knowledge of Cocrystal, or any of its Affiliates, threatened seeking the recall of any of the products or the revocation or suspension of any … or otherwise, (ii) without limiting the generality of Section 3.17, completed or to the knowledge of Cocrystal, pending proceedings seeking the recall
8-K
EX-2.1
9tvvk6
1 Dec 14
Entry into a Material Definitive Agreement
12:00am
8-K
99kv4
7 Jul 11
Acquires Biozone Laboratories, Inc. and Related Companies
12:00am
8-K
ybzifqlkjfurx0
19 May 11
Completion of Acquisition or Disposition of Assets
12:00am
8-K
EX-1.1
0pjgmazfjoe6h6cnu4l
30 Oct 19
Entry into a Material Definitive Agreement
4:38pm
8-K
EX-1.1
p1qygtva
20 Jul 18
Entry into a Material Definitive Agreement
4:50pm
8-K
EX-1.1
mw6km86fx6ho47
31 Oct 19
Entry into a Material Definitive Agreement
9:29am
8-K
EX-10.1
f53weg sjrd42uw
19 May 11
Completion of Acquisition or Disposition of Assets
12:00am
8-K
EX-1.1
ni2pixc2
2 May 18
Entry into a Material Definitive Agreement
4:13pm
8-K
EX-1.1
ckf3rn ddu
27 Aug 20
Entry into a Material Definitive Agreement
5:25pm